Table 1.
Number of incident cases of lung and bladder carcinomas, age-standardized incidence rates (ASR) with corresponding 95% confidence intervals (CI), by sex and age group. 1995–2009 in 14 municipalities.
| <75 Years | ≥75 Years | All Ages | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Men | Women | Men | Women | Men | Women | |||||||||||||
| N | ASR | 95% CI | N | ASR | 95% CI | N | ASR | 95% CI | N | ASR | 95% CI | N | ASR | 95% CI | N | ASR | 95% CI | |
| All cancer * | 3813 | 442.2 | (427.9–456.6) | 2716 | 314.9 | (302.5–327.4) | 1892 | 3383 | (3228.8–3537.3) | 1599 | 1593.4 | (1512.4–1674.4) | 5705 | 559.9 | (544.8–575) | 4315 | 366.1 | (353.7–378.5) |
| Bladder cancer | 304 | 34.3 | (30.4–38.2) | 79 | 8.6 | (6.7–10.6) | 193 | 339.5 | (291–388) | 74 | 74.2 | (56.6–91.8) | 497 | 46.5 | (42.3–50.8) | 153 | 11.4 | (9.2–13.3) |
| Lung cancer | ||||||||||||||||||
| All lung carcinoma | 527 | 58.4 | (53.4–63.5) | 153 | 16 | (13.4–18.7) | 274 | 496.5 | (437–555.9) | 122 | 126 | (102.8–149.1) | 801 | 75.9 | (70.5–81.3) | 275 | 20.4 | (17.7–23.1) |
| Adenocarcinoma | 131 | 14.6 | (12.1–17.2) | 58 | 6.5 | (4.8–8.2) | 55 | 100.7 | (73.8–127.6) | 24 | 26.8 | (15.7–37.8) | 186 | 18.1 | (15.4–20.8) | 82 | 7.3 | (5.6–9) |
| Squamous cell | 135 | 14.7 | (12.2–17.2) | 23 | 2.3 | (1.3–3.3) | 69 | 129.8 | (98.9–160.7) | 17 | 19.9 | (10.2–29.6) | 204 | 19.3 | (16.6–22) | 40 | 3 | (2–4) |
| Other | 261 | 29 | (25.5–32.6) | 72 | 7.2 | (5.5–8.9) | 150 | 266 | (222.9–309.1) | 81 | 79.3 | (61.4–97.2) | 411 | 38.5 | (34.7–42.4) | 153 | 10.1 | (8.3–11.9) |
Note: ASR calculated from age-standardized rates on 2001 EU population; (*): All cancers (non melanoma excluded).